Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
77,200,692
-
Share change
-
-10,550,209
-
Total reported value
-
$22,849,022
-
Put/Call ratio
-
41%
-
Price per share
-
$0.30
-
Number of holders
-
80
-
Value change
-
-$3,437,347
-
Number of buys
-
35
-
Number of sells
-
70
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q2 2025
As of 30 Jun 2025,
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,200,692 shares.
The largest 10 holders included
Nextech Invest, Ltd., Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, AQR CAPITAL MANAGEMENT LLC, Rock Springs Capital Management LP, BlackRock, Inc., SILVERARC CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.